Kensuke Ohse

Title: Kensuke Ohse: Innovator in Cancer Treatment

Introduction

Kensuke Ohse is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in cancer treatment. His innovative approach focuses on the development of therapeutic compositions that utilize monoclonal antibodies.

Latest Patents

Kensuke Ohse holds 1 patent for his invention titled "Therapeutic pharmaceutical composition employing anti-SLC6A6 antibody." This patent aims to provide a pharmaceutical composition for cancer treatment, which comprises a novel monoclonal antibody binding to SLC6A6 or its extracellular region, along with a chemotherapeutic agent conjugated therewith. The invention outlines a therapeutic method in which the monoclonal antibody or a therapeutic agent composed of the monoclonal antibody conjugated with a chemotherapeutic agent is used in combination with a chemotherapeutic agent. The composition includes an antibody conjugate that features a monoclonal antibody with higher affinity than conventional antibodies, recognizing native SLC6A6 or a native polypeptide of its extracellular region, conjugated with an anticancer agent effective against cancer and other hyperproliferative diseases.

Career Highlights

Kensuke Ohse is associated with Order-Made Medical Research Inc., where he continues to advance his research in therapeutic pharmaceuticals. His work is characterized by a commitment to improving cancer treatment methodologies through innovative scientific approaches.

Collaborations

Kensuke collaborates with notable colleagues, including Hiroyuki Satofuka and Shigeki Mukobata, who contribute to his research endeavors and enhance the impact of his inventions.

Conclusion

Kensuke Ohse's contributions to cancer treatment through his innovative patent demonstrate his dedication to advancing medical science. His work exemplifies the potential of targeted therapies in improving patient outcomes.